Anatomy of an ordinary drug company scam

At the pre-op office visit for my cataract surgery this fall, the scheduling clerk explained what would happen on the day of surgery. Handing me the last page of materials, she apologized because one of the eye drops, Bromday, isn’t available anymore. A new drug, Prolensa, was just released, she said, and handed me a $50 coupon to help pay for it. After more than five decades of experience with the drug industry as a physician and pharmacist,...

Read More